Myostatin (GDF-8) research has suggested is present in the muscle healing process and its nature is inhibiting myogenesis, which is the formation of muscular tissue, especially during embryonic development. Myostatin (GDF8) is a negative regulator of muscle growth in mammals, and loss-of-function mutations are associated with increased skeletal muscle mass in mice, cattle, and humans.
- Myostatin (also known as growth differentiation factor 8, abbreviated GDF-8) is a myokine, a protein produced and released by myocytes that acts on muscle cells’ autocrine function to inhibit myogenesis: muscle cell growth and differentiation. In humans, it is encoded by the MSTN gene. Myostatin is a secreted growth differentiation factor that is a member of the TGF beta protein family.
- GDF-8 / Myostatin Myostatin , Animals either lacking myostatin or treated with substances that block the activity of myostatin have significantly more muscle mass. Furthermore, individuals who have mutations in both copies of the myostatin gene have significantly more muscle mass and are stronger than normal. Blocking the activity of myostatin may have therapeutic applications in treating muscle-wasting diseases such as muscular dystrophy.